Plant-Based Autoimmune Modulation Protocol for Immune Regulation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for autoimmune diseases often have limited effectiveness, significant side effects, and fail to address the underlying immune dysregulation, while immunotherapy can trigger or exacerbate autoimmune responses, and lack personalization for individual variability.

Innovation Solution

A plant-based supplement protocol combining Vitamin D3, Vitamin K2, Magnesium Complex, dulcamara, and Trans-Resveratrol to modulate the immune system, reduce inflammation, and promote tissue regeneration, tailored to individual factors like age, weight, and symptom severity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional immunosuppressive medications are used to treat autoimmune diseases, then symptom management is achieved, but significant side effects and limited effectiveness occur

Engineering Contradiction:

Improvetreatment effectivenessVSAvoidadverse side effects

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the fundamental parameter of treatment approach from synthetic immunosuppressive drugs to plant-based compounds with immunomodulatory properties. This parameter change transforms the treatment mechanism from suppression to regulation, achieving better effectiveness while reducing harmful side effects through natural bioactive compounds like polyphenols and terpenoids

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite formulation combining multiple plant-derived compounds (curcumin, resveratrol, quercetin, gingerol, etc.) that work synergistically. This composite approach addresses the limited effectiveness of single-agent therapies while maintaining a favorable safety profile through the coordinated action of multiple natural constituents

Inventive Principle:

Principle #40Composite materials

2Reliability

If immunotherapy is used to treat diseases, then disease treatment is achieved, but autoimmune complications are triggered or exacerbated

Engineering Contradiction:

Improvedisease treatment efficacyVSAvoidautoimmune response activation

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful autoimmune response into a beneficial outcome by using plant-based compounds that modulate immune activity. These compounds transform the overactive immune system into a regulated state, turning the harmful autoimmune attack into a balanced immune function that protects rather than damages

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent introduces plant-based bioactive compounds as intermediary substances between the immune system and the triggering antigens. These intermediaries (polyphenols, terpenoids) mediate the immune response by binding to immune cells and modulating their activity, preventing direct harmful interactions while maintaining protective immunity

Inventive Principle:

Principle #24Intermediary (Mediator)

3Ease of operation

If traditional symptom management treatments are used, then immediate relief is achieved, but underlying immune dysregulation is not addressed

Engineering Contradiction:

Improvesymptom relief speedVSAvoidlong-term disease management

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

The patent takes preliminary action by addressing immune dysregulation before it progresses to severe symptoms. The plant-based compounds work proactively to regulate immune function and prevent the development of autoimmune attacks, rather than merely responding to established symptoms

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent introduces dynamic immunomodulation through plant compounds that can adapt their effect based on the body's needs. These compounds dynamically regulate immune activity, increasing suppression when inflammation is high and allowing normal function when balanced, creating a flexible long-term management system

Inventive Principle:

Principle #15Dynamics

4Ease of operation

If standardized treatment protocols are used, then treatment simplicity is maintained, but individual variability in disease manifestation is not accounted for

Engineering Contradiction:

Improvetreatment protocol simplicityVSAvoidpersonalization to individual factors

Core Design Contradiction:

Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent segments the treatment approach into multiple plant-based compounds with different mechanisms of action, allowing customization based on individual patient needs. Each compound (curcumin, resveratrol, quercetin, etc.) can be selected or combined according to the specific autoimmune condition and patient characteristics, maintaining simplicity through modular selection

Inventive Principle:

Principle #1Segmentation

Data Source

PatentUS20250325622A1Autoimmune Disease Modulation Protocol

Publication Date: 2025.10.23 PIMENTEL KEVEN A M

AI summary

The invention presents a groundbreaking approach to safer autoimmune disease modulation, combining vitamins, minerals, and plant-based compounds for immune regulation, anti-inflammatory effects, and tissue regeneration. Key ingredients include Vitamin D3, Vitamin K2, a Magnesium Complex, dulcamara root, and Trans-Resveratrol, synergistically balanced for optimal efficacy. This protocol offers personalized dosing, adaptable to individual needs based on age, weight, and symptom severity. Available in various forms like capsules and tablets, it caters to diverse patient preferences. The invention not only alleviates symptoms but also targets the root causes of autoimmune imbalances, marking a significant advancement in autoimmune care.